Abbott Laboratories has sued to prevent Watson Pharmaceuticals Inc. from commercializing a generic version of the cholesterol drug Niaspan before the drug’s patents expire.
Abbott sues to block sales of drug in generic form before patents expire
Last updated
What's New
BizPeople
Submit a BizPeople
Share new hires, promotions and employee accolades with the region's business leaders.
